What are the Potential Benefits of P-Glycoprotein Inhibitors in Cancer Therapy?
The primary benefit is overcoming drug resistance. By inhibiting P-gp, these agents can increase the intracellular concentration of chemotherapeutic drugs, improving their effectiveness. This could lead to better treatment outcomes, especially in cancers that are resistant to multiple drugs.
